Company Overview
HALOZYME THERAPEUTICS, INC.
HALORevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
1,397M
2025 FY
Net Income
317M
2025 FY
Shares Outstanding
120M
2025 FY
EPS
2.64USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1159036
Exchange
Nasdaq
Location
US